Close Menu

NEW YORK ─ Life sciences firm LGC said on Thursday that it has acquired infectious-disease antigen and antibody supplier Native Antigen Company (NAC) for an undisclosed amount.

Teddington, UK-based LGC said the deal strengthens its product offering to the IVD sector, which includes a range of quality assurance tools, immunoassay reagents, disease-state plasma, and probes and primers for molecular diagnostic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.